Stenting of the iliac arteries with the palmaz stent: Experience from a multicenter trial

Julio C. Palmaz, Jean C. Laborde, Frank J. Rivera, Carlos E. Encarnacion, James D. Lutz, Jonathan G. Moss

Research output: Contribution to journalArticlepeer-review

293 Scopus citations


Balloon-expandable, intraluminal stenting of the iliac arteries with the Palmaz stent was the subject of a multicenter study for 4 years. A total of 486 patients underwent 587 procedures. Four hundred and five patients had unilateral and 81 had bilateral iliac stent placements. Follow-up ranged from 1 to 48 months (mean 13.3±11 months). Sustained clinical benefit of the treated patients was obtained in 90.9% at 1 year, 84.1% at 2 years, and 68.6% at 43 months. Angiographic patency rate was 92%. Diabetes mellitus and poor runoff had significant negative influence on the clinical outcome. The 10% incidence of procedural complications was not altered by operator experience.

Original languageEnglish (US)
Pages (from-to)291-297
Number of pages7
JournalCardiovascular and Interventional Radiology
Issue number5
StatePublished - Sep 1992


  • Atherosclerosis
  • Iliac arteries
  • Intravascular stents
  • Percutaneous balloon angioplasty

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Stenting of the iliac arteries with the palmaz stent: Experience from a multicenter trial'. Together they form a unique fingerprint.

Cite this